{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:32:59Z","timestamp":1786714379017,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"DOI":"10.1007\/s11748-026-02379-4","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:51:00Z","timestamp":1786711860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A meta-analysis of cisplatin-based versus carboplatin-based adjuvant chemotherapy for completely resected non-small cell lung cancer"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-8260","authenticated-orcid":false,"given":"Masatsugu","family":"Hamaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yamanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Hyakutake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"21","key":"2379_CR1","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"JP Pignon","year":"2008","unstructured":"Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26(21):3552\u20139.","journal-title":"J Clin Oncol"},{"issue":"10308","key":"2379_CR2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","volume":"398","author":"E Felip","year":"2021","unstructured":"Felip E, Altorki N, Zhou C, Cs\u0151szi T, Vynnychenko I, Goloborodko O, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021;398(10308):1344\u201357.","journal-title":"Lancet"},{"key":"2379_CR3","volume-title":"Guidelines for diagnosis and treatment of lung cancer","author":"Japan Lung Cancer Society","year":"2023","unstructured":"Japan Lung Cancer Society. Guidelines for diagnosis and treatment of lung cancer. Tokyo: Kanehara & Co., Ltd.; 2023."},{"key":"2379_CR4","unstructured":"National Comprehensive Cancer Network. Non\u2013Small Cell Lung Cancer. Version 2024.1. NCCN Clinical Practice Guidelines in Oncology. Fort Washington (PA): National Comprehensive Cancer Network; 2024. Available from: https:\/\/www.nccn.org. Accessed April 2024."},{"issue":"4","key":"2379_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"PE Postmus","year":"2023","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non\u2013small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(4):339\u201357.","journal-title":"Ann Oncol"},{"key":"2379_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"JY Douillard","year":"2006","unstructured":"Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB\u2013IIIA non\u2013small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncology. 2006;7:719\u201327.","journal-title":"Lancet Oncology"},{"key":"2379_CR7","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs observation in resected non\u2013small-cell lung cancer. N Engl J Med. 2005;352:2589\u201397.","journal-title":"N Engl J Med"},{"issue":"11","key":"2379_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/jnci\/djk196","volume":"99","author":"A Ardizzoni","year":"2007","unstructured":"Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non\u2013small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;99(11):847\u201357.","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"2379_CR9","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/cncr.28679","volume":"120","author":"CD Williams","year":"2014","unstructured":"Williams CD, Gajra A, Ganti AK, Kelley MJ. Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer. Cancer. 2014;120(13):1939\u201347.","journal-title":"Cancer"},{"issue":"1","key":"2379_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lungcan.2014.01.017","volume":"84","author":"WJ Chang","year":"2014","unstructured":"Chang WJ, Sun JM, Lee JY, Ahn JS, Ahn MJ, Park K. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin. Lung Cancer. 2014;84(1):51\u20135.","journal-title":"Lung Cancer"},{"issue":"3","key":"2379_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.lungcan.2015.11.007","volume":"90","author":"G Schmid-Bindert","year":"2015","unstructured":"Schmid-Bindert G, Engel-Riedel W, Reck M, Schuette W, St\u00f6hlmacher J, Fischer JR, et al. A randomized phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II non-small-cell lung cancer. Lung Cancer. 2015;90(3):397\u2013404.","journal-title":"Lung Cancer"},{"issue":"1","key":"2379_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1078155217724595","volume":"25","author":"V Couillard-Montminy","year":"2019","unstructured":"Couillard-Montminy V, Gagnon PY, Fortin S, C\u00f4t\u00e9 J. Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer. J Oncol Pharm Pract. 2019;25(1):44\u201351.","journal-title":"J Oncol Pharm Pract"},{"key":"2379_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.lungcan.2019.11.009","volume":"141","author":"K Kubota","year":"2020","unstructured":"Kubota K, Kunitoh H, Seto T, Shimada N, Tsuboi M, Ohhira T, et al. Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503. Lung Cancer. 2020;141:32\u20136.","journal-title":"Lung Cancer"},{"issue":"1","key":"2379_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00280-020-04104-1","volume":"86","author":"SI Fukumoto","year":"2020","unstructured":"Fukumoto SI, Oizumi S, Harada M, Sukoh N, Nakano K, Fuke S, et al. A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703). Cancer Chemother Pharmacol. 2020;86(1):117\u201327.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2379_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12957-020-02041-0","volume":"18","author":"S Takashima","year":"2020","unstructured":"Takashima S, Imai K, Atari M, Matsuo T, Nakayama K, Sato Y, et al. Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study. World J Surg Oncol. 2020;18(1):263.","journal-title":"World J Surg Oncol"},{"key":"2379_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-026-03375-0","author":"M Hamaji","year":"2026","unstructured":"Hamaji M, Miyata R, Takeuchi J, Ozu N, Kohama T, Sumitomo R, et al. Cisplatin versus carboplatin as adjuvant chemotherapy for completely resected non-small cell lung cancer: a multicenter retrospective cohort study. Surg Today. 2026. https:\/\/doi.org\/10.1007\/s00595-026-03375-0.","journal-title":"Surg Today"},{"key":"2379_CR17","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","volume":"26","author":"GM Strauss","year":"2008","unstructured":"Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH Jr, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008;26:5043\u201351.","journal-title":"J Clin Oncol"},{"key":"2379_CR18","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1200\/JCO.2009.27.6204","volume":"28","author":"E Felip","year":"2010","unstructured":"Felip E, Rosell R, Maestre JA, Rodr\u00edguez-Paniagua JM, Mor\u00e1n T, Astudillo J, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer: a randomized controlled trial. J Clin Oncol. 2010;28:3138\u201345.","journal-title":"J Clin Oncol"},{"key":"2379_CR19","volume-title":"Redefining health care: creating value-based competition on results","author":"ME Porter","year":"2006","unstructured":"Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston: Harvard Business School Press; 2006."},{"key":"2379_CR20","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA, et al. Carboplatin dosage: prospective evaluation of a simple formula. J Clin Oncol. 1989;7:1748\u201356.","journal-title":"J Clin Oncol"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-026-02379-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-026-02379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:51:04Z","timestamp":1786711864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-026-02379-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":20,"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1007\/s11748-026-02379-4","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a meta-analysis based exclusively on data from previously published studies. Therefore, ethical approval was not required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was not required because this study did not involve direct participation of human subjects and used only data from previously published studies.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}